Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Copy number profiling of tumor suppressor genes in head and neck cancer.

Yalniz Z, Demokan S, Karabulut B, Ulusan M, Suoglu Y, Dalay N.

Head Neck. 2017 Feb;39(2):341-346. doi: 10.1002/hed.24593. Epub 2016 Oct 3.

PMID:
27696595
2.

Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.

Demokan S, Chuang AY, Pattani KM, Sidransky D, Koch W, Califano JA.

Oncol Rep. 2014 Feb;31(2):1014-20. doi: 10.3892/or.2013.2927. Epub 2013 Dec 16.

3.

Clusterin is a gene-specific target of microRNA-21 in head and neck squamous cell carcinoma.

Mydlarz W, Uemura M, Ahn S, Hennessey P, Chang S, Demokan S, Sun W, Shao C, Bishop J, Krosting J, Mambo E, Westra W, Ha P, Sidransky D, Califano J.

Clin Cancer Res. 2014 Feb 15;20(4):868-77. doi: 10.1158/1078-0432.CCR-13-2675. Epub 2013 Dec 10.

4.

Identification of guanine nucleotide-binding protein γ-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling.

Demokan S, Chuang AY, Chang X, Khan T, Smith IM, Pattani KM, Dasgupta S, Begum S, Khan Z, Liegeois NJ, Westra WH, Sidransky D, Koch W, Califano JA.

Int J Oncol. 2013 Apr;42(4):1427-36. doi: 10.3892/ijo.2013.1808. Epub 2013 Feb 6.

5.

MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.

Pattani KM, Soudry E, Glazer CA, Ochs MF, Wang H, Schussel J, Sun W, Hennessey P, Mydlarz W, Loyo M, Demokan S, Smith IM, Califano JA.

PLoS One. 2012;7(9):e45534. doi: 10.1371/journal.pone.0045534. Epub 2012 Sep 24.

6.

Role of DNA methylation in head and neck cancer.

Demokan S, Dalay N.

Clin Epigenetics. 2011 Aug;2(2):123-50. doi: 10.1007/s13148-011-0045-3. Epub 2011 Jul 9.

7.

Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer.

Demokan S, Chuang A, Suoğlu Y, Ulusan M, Yalnız Z, Califano JA, Dalay N.

Head Neck. 2012 Oct;34(10):1470-5. doi: 10.1002/hed.21949. Epub 2011 Nov 22.

PMID:
22106032
8.

Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer.

Yalniz Z, Demokan S, Suoglu Y, Ulusan M, Dalay N.

DNA Cell Biol. 2011 Jan;30(1):17-24. doi: 10.1089/dna.2010.1090. Epub 2010 Sep 22.

PMID:
20860434
9.

Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.

Pattani KM, Zhang Z, Demokan S, Glazer C, Loyo M, Goodman S, Sidransky D, Bermudez F, Jean-Charles G, McCaffrey T, Padhya T, Phelan J, Spivakovsky S, Bowne HY, Goldberg JD, Rolnitzky L, Robbins M, Kerr AR, Sirois D, Califano JA.

Cancer Prev Res (Phila). 2010 Sep;3(9):1093-103. doi: 10.1158/1940-6207.CAPR-10-0115. Epub 2010 Aug 26.

10.

Promoter hypermethylation in Indian primary oral squamous cell carcinoma.

Kaur J, Demokan S, Tripathi SC, Macha MA, Begum S, Califano JA, Ralhan R.

Int J Cancer. 2010 Nov 15;127(10):2367-73. doi: 10.1002/ijc.25377.

11.

Analysis of the hMSH2 gene variants in head and neck cancer.

Demokan S, Suoglu Y, Ulusan M, Dalay N.

DNA Cell Biol. 2010 Aug;29(8):449-57. doi: 10.1089/dna.2009.1013.

PMID:
20438357
12.

Identification of hypermethylated genes associated with cisplatin resistance in human cancers.

Chang X, Monitto CL, Demokan S, Kim MS, Chang SS, Zhong X, Califano JA, Sidransky D.

Cancer Res. 2010 Apr 1;70(7):2870-9. doi: 10.1158/0008-5472.CAN-09-3427. Epub 2010 Mar 9.

13.

Assessment of microsatellite instability in head and neck cancer using consensus markers.

Yalniz Z, Demokan S, Suoglu Y, Ulusan M, Dalay N.

Mol Biol Rep. 2010 Oct;37(7):3541-5. doi: 10.1007/s11033-010-0001-x. Epub 2010 Feb 25.

PMID:
20182807
14.

KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.

Demokan S, Chang X, Chuang A, Mydlarz WK, Kaur J, Huang P, Khan Z, Khan T, Ostrow KL, Brait M, Hoque MO, Liegeois NJ, Sidransky D, Koch W, Califano JA.

Int J Cancer. 2010 Nov 15;127(10):2351-9. doi: 10.1002/ijc.25248.

15.

TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization.

Sun W, Liu Y, Glazer CA, Shao C, Bhan S, Demokan S, Zhao M, Rudek MA, Ha PK, Califano JA.

Clin Cancer Res. 2010 Feb 1;16(3):857-66. doi: 10.1158/1078-0432.CCR-09-2604. Epub 2010 Jan 26.

16.

N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.

Demokan S, Suoglu Y, Gözeler M, Demir D, Dalay N.

Mol Biol Rep. 2010 Oct;37(7):3217-26. doi: 10.1007/s11033-009-9905-8. Epub 2009 Nov 8.

PMID:
19898993
17.

Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.

Kim MS, Louwagie J, Carvalho B, Terhaar Sive Droste JS, Park HL, Chae YK, Yamashita K, Liu J, Ostrow KL, Ling S, Guerrero-Preston R, Demokan S, Yalniz Z, Dalay N, Meijer GA, Van Criekinge W, Sidransky D.

PLoS One. 2009 Aug 7;4(8):e6555. doi: 10.1371/journal.pone.0006555.

18.

Methylation profiles in breast cancer.

Buyru N, Altinisik J, Ozdemir F, Demokan S, Dalay N.

Cancer Invest. 2009 Mar;27(3):307-12. doi: 10.1080/07357900802350814.

PMID:
19194828
19.

p53 genotypes and haplotypes associated with risk of breast cancer.

Buyru N, Altinisik J, Demokan S, Dalay N.

Cancer Detect Prev. 2007;31(3):207-13. Epub 2007 Jun 18.

PMID:
17574348
20.

Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer.

Demokan S, Suoglu Y, Demir D, Gozeler M, Dalay N.

Ann Oncol. 2006 Jun;17(6):995-9. Epub 2006 Mar 28.

PMID:
16569647
21.

Are serum levels of CD44 relevant in children with pediatric sarcomas?

Kebudi R, Ayan I, Yasasever V, Demokan S, Görgün O.

Pediatr Blood Cancer. 2006 Jan;46(1):62-5.

PMID:
16155927
22.

Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer.

Demokan S, Demir D, Suoglu Y, Kiyak E, Akar U, Dalay N.

Pathol Oncol Res. 2005;11(1):22-5. Epub 2005 Mar 31.

23.

Investigation of microsatellite instability in Turkish breast cancer patients.

Demokan S, Muslumanoglu M, Yazici H, Igci A, Dalay N.

Pathol Oncol Res. 2002;8(2):138-41.

Supplemental Content

Loading ...
Support Center